Compound Summary


  Compound Information
 GSK690693

Compound Name:

GSK690693

Compound CID:

16725726

Synonyms:

937174-76-0

GSK690693

GSK-690693

GSK 690693

(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo4,5-cpyridin-4-yl)-2-methylbut-3-yn-2-ol

More...

Iupac Name:

4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol

InChI:

InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1

InChIKey:

KGPGFQWBCSZGEL-ZDUSSCGKSA-N

Canonical Smiles:

CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N

Isomeric Smiles:

CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N

Molecular Weight:

425.5

Molecular Formula:

C21H27N7O3

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 GSK690693

Molecular Weight:

425.5

Molecular Formula:

C21H27N7O3

Hydrogen Bond Donor Count:

3

Hydrogen Bond Acceptor Count:

9

Rotatable Bond Count:

7

Heavy Atom Count:

31

Complexity:

680

  Synonyms
 GSK690693

GSK690693 GSK690693

937174-76-0

GSK690693

GSK-690693

GSK 690693

(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo4,5-cpyridin-4-yl)-2-methylbut-3-yn-2-ol

4-2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3S)-3-piperidinylmethoxy-1H-imidazo4,5-cpyridin-4-yl-2-methyl-3-butyn-2-ol

pan-Akt inhibitor GS690693

CHEBI:90677

GWH480321B

4-2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3S)-piperidin-3-ylmethoxyimidazo4,5-cpyridin-4-yl-2-methylbut-3-yn-2-ol

(R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMIDAZO4,5-CPYRIDIN-4-YL)-2-METHYLBUT-3-YN-2-OL

4-2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3S)-piperidin-3-ylmethoxy-1H-imidazo4,5-cpyridin-4-yl-2-methylbut-3-yn-2-ol

4-{2-(4-Amino-1,2,5-Oxadiazol-3-Yl)-1-Ethyl-7-(3s)-Piperidin-3-Ylmethoxy-1h-Imidazo4,5-Cpyridin-4-Yl}-2-Methylbut-3-Yn-2-Ol

UNII-GWH480321B

4-2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3S)-3-piperidinylmethoxy)-1H-imidazo4,5-cpyridin-4-yl-2-methyl-3-butyn-2-ol

G93

compound 3g PMID 18800763

SCHEMBL310452

CHEMBL494089

GTPL5196

BDBM25013

DTXSID60239551

EX-A031

BCP01721

MFCD18711681

NSC766991

NSC800766

s1113

ZINC34285211

AKOS015904356

AT18727

BCP9000745

CCG-264825

DB12745

NSC-766991

NSC-800766

NCGC00263181-01

AC-23166

AS-16204

BG174974

HY-10249

GSK690693,GSK-690693

SW218127-2

GSK690693, >=98% (HPLC)

A25176

174G760

J-502225

Q27077916

(-)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-3-BUTYN-2-OL

(R)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-yl-MeO)-1H-imidazo4,5-cpyridin-4-yl)-2-Me-but-3-yn-2-ol

3-BUTYN-2-OL, 4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-

4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-3-BUTYN-2-OL, (-)-

4-2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{(3S)-piperidin-3-ylmethoxy}-1H-imidazo4,5-cpyridin-4-yl-2-methylbut-3-yn-2-ol

  Experimental Data
 GSK690693

Species Dosage Unit CG Lifespan(AVG/MED days) TG Lifespan(AVG/MED days) Lifespan Change(AVG/MED%) CG Lifespan(MAX days) TG Lifespan(MAX days) Lifespan Change(MAX%) Significant Strain Gender PubMed Active Label
Drosophila melanogaster 10 umol/L NS WDah FEMALES 35065134 Inactive
Drosophila melanogaster 5 umol/L 61.4 66.6 8.5 S WDah FEMALES 35065134 Active
Drosophila melanogaster 1 umol/L NS WDah FEMALES 35065134 Inactive
  Experimental Data Visualization
 GSK690693

  Statistics Data
 GSK690693

Species Lifespan Change(AVG/MED%) Lifespan Change(MAX%) Count Reference Count Data point
Drosophila melanogaster 8.5 1 3
  Statistics Data Visualization
 GSK690693